How effective is Adderall 20 for Narcolepsy? (a real world drug study)
Summary:
Overall ratings: 3.6/5 Long term ratings: 3.6/5
This is a phase IV clinical study of how effective Adderall 20 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is for Narcolepsy and for what kind of people. The study is created by eHealthMe from 61 Adderall 20 users and is updated continuously.
What is Adderall 20?
Adderall 20 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 2,719 Adderall 20 users. Check the latest studies of Adderall 20.
What is Narcolepsy?
Narcolepsy (brain's inability to regulate sleep-wake cycles normally) is found to be associated with 431 drugs and 737 conditions by eHealthMe. Check the latest studies of Narcolepsy.
61 people are studied for taking Adderall 20 in Narcolepsy
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Adderall 20 effectiveness for Narcolepsy (number of people):
Overall:
- not at all: 1
- somewhat: 6
- moderate: 20
- high: 24
- very high: 10
Long Term:
- not at all: 0
- somewhat: 3
- moderate: 12
- high: 16
- very high: 4
Gender of people who take Adderall 20 for Narcolepsy *:
- female: 73.77 %
- male: 26.23 %
Age of people who take Adderall 20 for Narcolepsy *:
- 0-1: 1.6400000000000001 %
- 2-9: 0.0 %
- 10-19: 1.6400000000000001 %
- 20-29: 16.39 %
- 30-39: 31.15 %
- 40-49: 27.87 %
- 50-59: 11.48 %
- 60+: 9.84 %
Who find Adderall 20 more effective for Narcolepsy?
Gender of people who take Adderall 20 for Narcolepsy *:
- female: 79.41 %
- male: 20.59 %
Age of people who take Adderall 20 for Narcolepsy *:
- 0-1: 2.94 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 17.65 %
- 30-39: 32.35 %
- 40-49: 32.35 %
- 50-59: 11.76 %
- 60+: 2.94 %
* Approximation only. Some reports may have incomplete information.
Do you take Adderall 20?
- You can start a phase IV clinical trial to monitor Adderall 20 safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
- Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Adderall 20 (2,719 reports)
Treatments, associated drugs and conditions:
- Narcolepsy (79,888 reports)
How the study uses the data?
The study is based on amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate (the active ingredients of Adderall 20) and Adderall 20 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cisplatin and Novorapid - a second ago
- Adenomyosis and Pain - 4 seconds ago
- Could Pentamidine Isethionate cause Constipation? - 7 seconds ago
- Could Calquence cause Poor Quality Sleep? - 15 seconds ago
- Could Astelin cause Tinnitus Aggravated? - 15 seconds ago
- Could Fish Oil cause Seizure Like Phenomena? - 15 seconds ago
- Drug interactions of Epipen and Clonazepam - 15 seconds ago
- Drug interactions of Atenolol and Envarsus Xr - 21 seconds ago
- Could Compazine cause Hyponatremia? - 29 seconds ago
- Drug interactions of Advair Hfa and Xarelto - 29 seconds ago